Dermatology
| Psoriasis
Dermatology
Psoriasis
Long term psoriasis control with guselkumab versus secukinumab and ixekizumab among bio-experienced patients: analysis of drug persistence in large claims database
book_2
Source:
EADV Congress 2023 - Poster session
calendar_today
Published on Medfyle:
November 2023
In this medfyle
This study describes the treatment persistence and treatment switching among bio-experienced psoriasis patients starting on guselkumab, secukinumab, or ixekizumab.
Presenting Author
About this Medfyle
Read more
arrow_downward
Hide
arrow_upward
This is a summary of a presentation given at the EADV Congress 2023. The content is developed by Infomedica in collaboration with the EADV.
The information and data provided is for information purposes only. The presenting author(s) of the original presentation had no involvement in the creation of this content. The viewpoints expressed may not represent Infomedica, or the EADV.
©2023 Infomedica. All rights reserved.
